TOI — Starling Oncology, Inc.
Price · 2024-08-26 → 2026-08-03
485 daily closes shownAnonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2021-11-15.
Performance
Technicals
Others in Healthcare
Insider transactions (Form 4)
| date | insider | what | shares | price | value |
|---|---|---|---|---|---|
| 2026-08-14 | Chernett Jorey 10% owner | Open-market purchase | 12.0K | 6.54 | 78.5K |
| 2026-07-27 | Johnson Karen Marie Director | Grant or award | 31.1K | 0.00 | 0 |
| 2026-07-27 | Kaushal Mohit Director | Grant or award | 33.1K | 0.00 | 0 |
| 2026-07-27 | Hively Brad Director | Grant or award | 27.1K | 0.00 | 0 |
| 2026-07-27 | TZOUMAKAS KIMBERLY JO Director | Grant or award | 29.1K | 0.00 | 0 |
| 2026-07-27 | STOLPER MARK Director | Grant or award | 31.1K | 0.00 | 0 |
| 2026-07-27 | McGeorge Anne Director | Grant or award | 41.2K | 0.00 | 0 |
| 2026-07-27 | Pacala Mark L Director | Grant or award | 30.1K | 0.00 | 0 |
| 2026-07-21 | Chernett Jorey 10% owner | Open-market purchase | 18.0K | 5.27 | 94.9K |
| 2026-07-14 | Podnos Yale Chief Medical Officer | Open-market sale 10b5-1 plan | 18.0K | 6.43 | 115.6K |
Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →
Largest institutional holders
| manager | value | shares |
|---|---|---|
| BlackRock, Inc. | 13.6M | 4.4M |
| VANGUARD CAPITAL MANAGEMENT LLC | 10.7M | 3.5M |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 10.3M | 3.4M |
| Kanen Wealth Management LLC | 8.5M | 2.8M |
| JOSH ARNOLD INVESTMENT CONSULTANT, LLC | 7.6M | 2.5M |
| Balyasny Asset Management L.P. | 5.6M | 1.8M |
| GEODE CAPITAL MANAGEMENT, LLC | 5.4M | 1.8M |
| WEXFORD CAPITAL LP | 5.3M | 1.7M |
| CenterBook Partners LP | 4.8M | 1.6M |
| STATE STREET CORP | 4.5M | 1.5M |
13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →
Latest SEC filings
| form | filed | period | |
|---|---|---|---|
| 144 | 2026-08-21 | — | on EDGAR ↗ |
| 8-K | 2026-08-21 | 2026-08-20 | on EDGAR ↗ |
| 4 | 2026-08-17 | 2026-08-13 | on EDGAR ↗ |
| 10-Q | 2026-08-06 | 2026-06-30 | on EDGAR ↗ |
| 8-K | 2026-08-06 | 2026-08-06 | on EDGAR ↗ |
| 8-K | 2026-08-03 | 2026-07-28 | on EDGAR ↗ |
| 4 | 2026-07-29 | 2026-07-27 | on EDGAR ↗ |
| 4 | 2026-07-29 | 2026-07-27 | on EDGAR ↗ |
Short selling
This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →
Recent headlines
- Starling Oncology, Inc. (TOI) filed form 8-K · 2026-08-21 · SEC EDGAR
- Starling Oncology, Inc. (TOI) filed form 144 · 2026-08-21 · SEC EDGAR
Ask the AI about TOI
The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.
Everything on this page is live in the terminal.
Charts, filings, insider flow and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →